M
$ Value
$0
Shares
15,211
Price
$0
Filed
Mar 17
Insider
Name
Pendarvis Christiane
Title
—
CIK
0001965920
Roles
Director
Transaction Details
Transaction Date
2026-03-13
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. | The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with : (i) 1/3 of the RSUs vesting on March 15, 2024, (ii) 1/3 of the RSUs vesting on March 15, 2025, and (iii) 1/3 of the RSUs vesting on March 15, 2026.
Filing Info
Pendarvis Christiane's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | HIMS | M | — |
| 2026-03-13 | HIMS | M | $0 |
| 2025-08-06 | HIMS | A | $0 |
| 2025-06-12 | HIMS | M | — |
| 2025-06-12 | HIMS | M | $0 |
Other Insiders at HIMS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Dudum Andrew
Chief Executive Officer
|
— | — | 2026-04-09 |
|
Boughton Soleil
Chief Legal Officer
|
— | $473K | 2026-04-20 |
|
Carroll Patrick Harrison
Chief Medical Officer
|
— | — | 2026-03-13 |
|
Autor Deborah M.
Chief Policy Officer
|
— | — | 2026-03-13 |
|
Becklund Irene
PAO
|
— | $137K | 2026-03-17 |
|
Okupe Oluyemi
Chief Financial Officer
|
— | $2.5M | 2026-04-20 |
|
Chi Michael
Chief Operating Officer
|
— | $2.4M | 2026-03-17 |
| Pendarvis Christiane | — | — | 2026-03-13 |
|
Elshenawy Mohamed
CTO
|
— | — | 2026-03-11 |